• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Center for Harm Reduction Services

    The Maryland Department of Health's Center for Harm Reduction Services was established in 2019 to centralize harm reduction activities across the Department. The Center is housed with the Infectious Disease Prevention and Health Services Bureau in the Prevention and Health Promotion Administration. The Center oversees the Overdose Response Program, Syringe Services Program, naloxone distribution, harm reduction grants, and various workforce development, training, and technical assistance activities. Information about each of the Center's areas of work is linked below. 

    The Center's strategic goal is to reduce substance-related morbidity and mortality by optimizing services for people who use drugs. ​The Center for Harm Reduction Services envisions a Maryland where: 

    • Health care and social service systems meet the needs of people who use drugs in a comprehensive, community-based manner;

    • People who use drugs have equitable access to high-quality care; and

    • Services provided to people who use drugs are free from stigma and discrimination.

    *New Grant Opportunity*

    Maryland Harm Reduction Housing Landscape and Needs Assessment

    The Center for Harm Reduction Services is seeking 1-2 partners to conduct a landscape and needs assessment on housing for people who use drugs. The goal is to understand housing options available to people actively using drugs, the policy, funding and programmatic barriers they face, and identify ways in which the Center can direct resources to improve housing availability. The ideal applicant will have a strong understanding of housing first models and staff with experience working with people who use drugs, and may be a nonprofit organization or academic institution.

    The Request for Applications is open on the eMaryland Marketplace public portal under: Maryland Harm Reduction Housing Landscape and Needs Assessment (PHPA 1598 BPM024470). The opportunity closes July 1, 2021 at 2:00 PM

    A Pre-Application webinar was held via Google Meets on June 8, 2021 from 3:30 PM - 4:30 PM to provide information about the grant opportunity and application process. The transcript and slide-deck from the webinar are below.

    ​*New Statewide Standing Order*

    Statewide Standing Order for Pharmacy Dispensing

    Dr. Jinlene Chan, MD, MPH, Deputy Secretary for Public Health, Maryland Department of Health (MDH), has issued a new statewide standing order allowing all Maryland licensed pharmacists to dispense naloxone, including any necessary supplies for administration, to any individual. The statewide standing order and guidance is available below. The standing order will be faxed to Maryland pharmacies the week of June 1, 2021. Any pharmacists that required a tamper-proof (faxed) copy of the standing order for Medicaid billing purposes can request it from mdh.naloxone@maryland.gov after June 4. 


    COVID-19 and Overdose Response Grants Initiative--closed​

    The following Request for Applications has now closed on the eMaryland Marketplace public portal: COVID-19 and Overdose Response Grants Initiative​ (ID number BPM024065 or PHPA 1527). Applications are under review and award notices are tentatively planned for mid-July 2021. ​

    COVID-19 and Harm Reduction Information and Resources

    The Center for Harm Reduction Services administers the Overdose Response Program, which provides the means for training bystanders to administer naloxone in the event of an opioid overdose. MDH authorizes local entities as Overdose Response Programs, allowing them to provide overdose education and dispense naloxone through partnerships with prescribers. 


    The Center for Harm Reduction administers the Maryland Syringe Services Program, reviewing new applications, managing program reporting, issuing program guidance, and providing TA and support to approved programs. The Center for Harm Reduction Services also holds quarterly meetings of the Standing Advisory Committee on Opioid-Associated Disease Prevention and Outreach. These meetings are open to the public. 

    ACCESS is the Center's centralized platform for harm reduction resources for local health departments and community-based organizations. Resources are provided through ACCESS with the goal of reducing substance-related morbidity and mortality by optimizing services for people who use drugs. ACCESS stands for '​Advancing Cross-Cutting Engagement and Service Strategies for People Who Use Drugs.' Please contact mdh.access@maryland.gov with any questions. 


    The Maryland Department of Health, Center for Harm Reduction Services partners with the Maryland Harm Reduction Training Institute (MaHRTI) to build the capacity of Maryland's harm reduction workforce to provide optimal services to people who use drugs. For more information visit www.bhsbaltimore.org/mahrti​ or contact mahrti@bhsbaltimore.org. The Center also provides other workforce development and training, including the Regrounding Our Response initiative and Law Enforcement Assisted Diversion training. 

    ​Additional Resources